Amnon PeledM.Sc, Ph.D
Prof. Amnon Peled is the founder and Chief Scientific Officer of Biokine Therapeutics Ltd. Prof. Peled is a world-renowned expert in chemokine research, specifically on the CXCR4 receptor. He has published over 80 peer-reviewed papers in prestigious journals, such as Blood, JCI and Science. Prof. Peled is currently a Professor at the Gene Therapy Institute, Hadassah Medical Center, Jerusalem where he directs a laboratory focusing on the role of chemokines and chemokine receptors for the treatment of cancer and immune diseases. Professor Peled’s work experience includes Millennium Pharmaceuticals Inc., where he was the head of a group studying CXCR4 function in allergy. Prof. Peled has a Ph.D. from the Department of Cell Biology at the Weizmann Institute of Science.